Product Information
TEMAZEPAM 7.5 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.9116 per EA under NDC 00904643604. Its NADAC has been published 583 times since Apr 29, 2015.
Strength
7.5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904643604
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA071457On Market Since
3/25/2015
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 7.5 MG CAPSULE has been published 583 times since Apr 29, 2015, and over the history we have for it it has declined 78.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9116 per EA |
|---|---|
| All-time high | $4.4196 (Jul 15, 2015) |
| All-time low | $0.7393 (Nov 20, 2024) |
| 52-week high | $0.9430 |
| 52-week low | $0.7894 |
| Median price | $1.6205 |
| Average price | $1.9756 |
| Largest weekly change | +51.7% (Aug 21, 2024) |
| Weeks tracked | 583 |
| Tracking since | Apr 29, 2015 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 7.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 7.5 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.9116 per EA (NDC 00904643604), effective Jun 24, 2026.
How has the price of TEMAZEPAM 7.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has declined 78.3%. It has been tracked across 583 weekly CMS publications since Apr 29, 2015.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 7.5 MG CAPSULE?
Since Apr 29, 2015, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has ranged from a low of $0.7393 (Nov 20, 2024) to a high of $4.4196 (Jul 15, 2015), with a median of $1.6205 per EA.
Are there cheaper alternatives to TEMAZEPAM 7.5 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TEMAZEPAM 7.5 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMAZEPAM 7.5 MG CAPSULE?
TEMAZEPAM 7.5 MG CAPSULE (NDC 00904643604) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification